Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and AnxietyCreativeJune 4, 2024 June 4, 2024 Silo Pharma, Inc. (Nasdaq: SILO) a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments,...
